Àngel Rivero

1.0k total citations
6 papers, 6 citations indexed

About

Àngel Rivero is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Àngel Rivero has authored 6 papers receiving a total of 6 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Virology. Recurrent topics in Àngel Rivero's work include HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Àngel Rivero is often cited by papers focused on HIV/AIDS Research and Interventions (4 papers), HIV/AIDS drug development and treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). Àngel Rivero collaborates with scholars based in Spain and Israel. Àngel Rivero's co-authors include Pep Coll, Oriol Estrada, José Moltó, Yesika Díaz, Bonaventura Clotet, Jordi Puig, Lucía Bailón, Michael Meulbroek, Cristina Agustí and Cristina Miranda and has published in prestigious journals such as PLoS ONE, PLoS Pathogens and BMJ Open.

In The Last Decade

Àngel Rivero

2 papers receiving 6 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Àngel Rivero Spain	2	5	3	3	2	2	6	6
Anmol Goyal India	2	4 0.8×	2 0.7×	5 1.7×		2 1.0×	5	12
Gavin M. Sowa United States	2	3 0.6×	2 0.7×	3 1.0×	3 1.5×		2	8
Aja Sanzone United States	3	7 1.4×	4 1.3×	3 1.0×	3 1.5×		3	13
Carlos Bibiano Spain	3	4 0.8×	5 1.7×	5 1.7×	3 1.5×		6	16
Samuel Jeske Germany	3	5 1.0×	2 0.7×	2 0.7×	4 2.0×		7	10
John Otomba Democratic Republic of the Congo	2	5 1.0×	3 1.0×	3 1.0×	1 0.5×		4	13
Zubaidah Said Singapore	3	5 1.0×	4 1.3×	5 1.7×	1 0.5×	1 0.5×	4	11
Carmen Rubio‐Muñiz Spain	2	6 1.2×	4 1.3×	6 2.0×			2	8
Cathy Rowe United Kingdom	2	4 0.8×	5 1.7×	5 1.7×	1 0.5×		4	8
Julia Montero‐Menárguez Spain	2	7 1.4×	4 1.3×	6 2.0×			3	8

Countries citing papers authored by Àngel Rivero

Since Specialization

Citations

This map shows the geographic impact of Àngel Rivero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Àngel Rivero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Àngel Rivero more than expected).

Fields of papers citing papers by Àngel Rivero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Àngel Rivero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Àngel Rivero. The network helps show where Àngel Rivero may publish in the future.

Co-authorship network of co-authors of Àngel Rivero

This figure shows the co-authorship network connecting the top 25 collaborators of Àngel Rivero. A scholar is included among the top collaborators of Àngel Rivero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Àngel Rivero. Àngel Rivero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Bailón, Lucía, Àngel Rivero, Pep Coll, et al.. (2025). Strategies to Minimize Time From HIV Acquisition to ART Initiation: The Barcelona Early-cART Program. Open Forum Infectious Diseases. 12(9). ofaf545–ofaf545.

2.

Negredo, Eugènia, Vicenç Falcó, Àngel Rivero, et al.. (2025). Exploring the acceptability, appropriateness, feasibility and satisfaction of an implementation strategy for out-of-HOspital administration of the Long-Acting combination of cabotegravir and rilpivirine as an optional therapy for HIV in Spain (the HOLA study)—a hybrid implementation-effectiveness, phase IV, double-arm, open-label, multicentric study: study protocol. BMJ Open. 15(4). e088514–e088514.

3.

Puertas, María C., Lucía Bailón, Víctor Urrea, et al.. (2025). Rapid clearance of inducible HIV-1 proviruses after initiation of antiretroviral therapy. PLoS Pathogens. 21(9). e1013466–e1013466.

4.

Folch, Cinta, Clara Suñer, Yesika Díaz, et al.. (2023). Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection. Sexually Transmitted Infections. 99(8). 541–547. 3 indexed citations

5.

Seguí, Francesc López, Pep Coll, Michael Meulbroek, et al.. (2023). Cost-effectiveness analysis of the daily HIV pre-exposure prophylaxis in men who have sex with men in Barcelona. PLoS ONE. 18(1). e0277571–e0277571. 3 indexed citations

6.

Rivero, Àngel, et al.. (2018). Primary bone lymphoma: Report of 7 cases. Medicina Clínica (English Edition). 151(10). 421–422.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact